GABA-A and NMDA receptor subunit mRNA expression is altered in the caudate but not the putamen of the postmortem brains of alcoholics.
Park HJ, Lee S, Ju E, Jones JA, Choi I. Alternative transcription of sodium/bicarbonate transporter SLC4A7 gene enhanced by single nucleotide polymorphisms. Physiol Genomics 49: 167-176, 2017. First published January 13, 2017; doi:10.1152/physiolgenomics.00112.2016.-Genome-wide association studies have identified the single nucleotide polymorphism (SNP) rs3278 in the human SLC4A7 gene as one of the marker loci for addiction vulnerability. This marker is located in an intron of the gene, and its genomic role has been unknown. In this study, we examined rs3278 and three adjacent SNPs prevalent in alcoholics for their effects on an alternative promoter that would lead to the production of the NH2-terminally truncated protein NBCn1⌬N450, missing the first 450 amino acids. Analysis of the transcription start site database and a promoter prediction algorithm identified a cluster of three promoters in intron 7 and two short CpG-rich sites in intron 6. The promoter closest to rs3278 showed strong transcription activity in luciferase reporter gene assays. Major-to-minor allele substitution at rs3278 resulted in increased transcription activity. Equivalent substitutions at adjacent rs3772723 (intron 7) and 13077400 (exon 8) had negligible effect; however, the substitution at nonsynonymous rs3755652 (exon 8) increased the activity by more than twofold. The concomitant substitution at rs3278/rs3755652 produced an additive effect. The rs3755652 had more profound effects on the promoter than the upstream regulatory CpG sites. The amino acid change E326K caused by rs3755652 had negligible effect on transporter function. In HEK 293 cells, NBCn1⌬N450 was expressed in plasma membranes, but at significantly lower levels than the nontruncated NBCn1-E. The pH change mediated by NBCn1⌬N450 was also low. We conclude that rs3278 and rs3755652 stimulate an alternative transcription of the SLC4A7 gene, increasing the production of a defective transporter. SLC4A7; NBCn1; bicarbonate transporter, rs3278 NBCN1 (SLC4A7) is a plasma membrane ion transporter that moves Na ϩ and HCO 3 Ϫ into the cells (1, 12) . This movement is essential for regulation of intracellular pH (pH i ), plasma and extracellular fluid pH, and transepithelial HCO 3 Ϫ transport. The pH regulation mediated by NBCn1 affects a variety of physiological processes in multiple tissues or organs. For example, in vascular smooth muscle, NBCn1 contributes to vascular tone regulation and promotes arterial remodeling (6). In cardiac tissues, NBCn1 is located to lateral sarcolemma and protects excitation-contraction coupling in the t-tubules (20) , In neural tissues, this transporter affects glutamate excitotoxicity mediated by acute brain injury or chronic metabolic acidosis (34) . In osteoclasts, it influences the ability of a colony-stimulating factor to prolong the survival of osteoclasts (8) .
Genome-wide association studies show that some single nucleotide polymorphisms (SNPs) in the human SLC4A7 gene or its flanking region are associated with diseases or pathological states (2, 3, 19, 21, 25, 33, 42, 43) . In particular, rs3278 has been linked to polysubstance abuse (41, 42) . This SNP, initially named rSA1, was identified as one of the marker loci prevalent in African American and European American abusers who used cocaine, heroin, cannabis, or nicotine more than five times (42) . The minor allele frequency of rs3278 is also higher in abusers selected from the Collaborative Study on the Genetics of Alcoholism (COGA) pedigrees, as well as abusers recruited by the National Institute on Drug Abuse (NIDA) (25) . Thus, evidence for rs3278 association with substance abuse is strong. Nonetheless, the marker is located in an intron region that is far downstream of the gene transcription site, and its genomic role has been unclear.
The SLC4A7 gene maps to chromosome 3q21 in humans and produces multiple transporter isoforms. According to the Ensembl annotation project (http://useast.ensembl.org), the principal protein isoform for the gene is SLC4A7-001 (alias NBCn1-A or isoform 1) with 1,214 amino acids. Other isoforms consist of different numbers of amino acids, ranging from 801 to 1,259, due to splicing events in the cytoplasmic NH 2 -or COOH-terminal domain and to alternative transcriptions (7, 31) . All isoforms contain predicted transmembrane domains essential for function (14) , at least part of the cytoplasmic NH 2 -terminal domain and the COOH-terminal domain that interacts with other proteins in cell-specific manners (36) . Among these isoforms, SLC4A7-003 lacks the first 450 amino acids in the NH 2 -terminal domain (hereafter, NBCn1⌬N450). NBCn1⌬N450 is also referred to as "H7C3C4" in the Uniprot protein database (http://www.uniprot.org). In addition, this NH 2 -terminally truncated isoform contains unique 15 amino acids in the region corresponding to position 451-465 due to a frame shift in exon 9. The transcription and translation start sites for NBCn1⌬450 have been suggested to be different from those for other isoforms.
In this study, we hypothesized that rs3278 affects an alternative transcription of the SLC4A7 gene, which induces the production of NBCn1⌬N450. To test this hypothesis, we used bioinformatics tools to identify promoter sites and gene regulatory sites in the genomic region adjacent to rs3278. We then examined transcription activity in identified sites by luciferase reporter assays. We then determined the effects of the major-to-minor allele substitution at rs3278 on alternative transcription activity. Parallel substitution experiments were performed with adjacent SNPs rs3772723, rs13077400, and rs3755652, all of which are prevalent in abusers selected from the COGA study (25) . In other experiments, NBCn1⌬N450 was expressed in HEK 293 cells and its ability to transport HCO 3 Ϫ and express in membrane was assessed. The results show that an alternative promoter site is located near rs3278 and regulated by this polymorphism and other SNPs. The implication of the rs3278mediated alternative transcription for addiction physiology is discussed.
MATERIALS AND METHODS
All experiments described in this study were conducted according to the National Institute of Health guidelines for research on animals. Experimental protocols were approved by the Institutional Animal Care and Use Committee at Emory University.
Identification of SLC4A7 alternative promoters. Human SLC4A7 genomic sequence (accession number: ENSG00000033867) was analyzed using Ensembl release 87 (http://www.ensembl.org) and the dsSNP database hosted by NCBI with the human genome assembly GRCh38.p7. Alternative promoter sites were identified using the Database of Transcription Start Sites (DBTSS) release 8.0 (http:// dbtss.hgc.jp/). The search was set to adult human tissues for cell category and 500 bp for cluster distance. Identified clusters were further analyzed using the Neural Network Promoter Prediction (http://www.fruitfly.org/seq_tools/promoter.html) to determine promoter sequences. The minimum promoter score was 0.8 to remove nonspecific background detection. The CpG-rich regions were identified using the EMBL Emboss CpGplot prediction with the thresholds to length of Ͼ 50 bp, GC content of Ͼ 30%, and Obs/Exp ratio of Ͼ 0.4.
Luciferase gene assay. Human genomic DNA was purchased from Promega (Madison, WI). The 5,092 bp DNA corresponding to the region of exon 6 to exon 8 in the SLC4A7 gene was obtained by PCR with the primers: AGGAGTTGCATCCTCAATGG (forward) and TCCTCAGGCGGATGAATTAC (reverse). The reaction was done with the Expand High Fidelity PCR System (Roche, Indianapolis, IN) at 95°C for 5 min for an initial denaturation, then 30 cycles at 95°C for 30 s, 55°C for 1 min, and 72°C for 1 min. The final elongation was at 72°C for 7 min. The PCR product was subcloned and sequenced. The product was then inserted into KpnI and XhoI sites upstream of the firefly luciferase reporter gene in pGL3-Basic Vector (Promega). Human neuroblastoma SH-SY5Y cells were seeded in 12-well plates and incubated overnight in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 50 units/ml of penicillin, and 50 g/ml streptomycin. Cells at the density of 2 ϫ 10 5 per well were transfected with 1.5 g of pGL/SLCA47 plasmid and 20 ng of pRL-TK vector, which provides constitutive expression of Renilla luciferase. The control was the pGL3-Basic vector with pRL-TK vector. Transfection was done using Lipofectamine 2000 according to the manufacturer's protocol. Transfected cells were incubated in reduced serum medium Opti-MEM (Invitrogen) for 6 h and then in incubation media for 48 h. Luciferase activity was measured by the Dual-Luciferase Reporter Assay System (Promega) using the TD 20/20 Luminometer (Turner Design, Sunnyvale, CA). The value for firefly luciferase activity was normalized to the value for Renilla luciferase activity. Assays were conducted in triplicate in minimum three independent experiments.
Point mutation and deletion constructs. Major alleles at rs3278, rs3772723, rs13077400, and rs3755652 were mutated to minor alleles using a QuikChange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA). The mutations (in forward direction) were G to A for rs3278, G to C for rs3772723, A to G for rs13077400, and C to T for rs3755652. PCR was performed 16 cycles at 95°C for 30 s, 55°C for 1 min, and 68°C for 10 min. The final extension was done at 68°C for 10 min. For deletion constructs, a series of deletions were made from the 5= end of the above 5,152 bp DNA fragment using restriction enzyme digestion. The deletion of 3,352 bp fragment maintains all three putative promoters, while the deletion of 3,942 bp maintains the second and third promoters and the deletion of 4,212 bp maintains the third promoter. In addition, the 2,105 bp containing three promoters was inversely oriented. Point mutations and deletion constructs were confirmed by sequencing.
Measurement of pH i in HEK 293 cells. NBCn1⌬450 (SLC4A7-003; Ensembl accession number: ENST00000419036.5) was constructed by PCR with the forward primer corresponding to 48 nucleotides in exon 9 and 26 nucleotides in exon 11 and the reverse primer to the downstream region common to all variants. The PCR product was ligated to the remaining COOH-terminal part of pCDNA3/ NBCn1-E. The resultant plasmid pCDNA3.1/NBCn1⌬450 was verified by sequencing. The transporter function was determined by pH i measurement in HEK 293 cells using the protocol described previously (30) . Briefly, cells grown on a coverslip (over 60% confluence) were loaded with 6.5 M of 2,7-bis(2-carboxyethyl)-5 (6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) for 10 min and then mounted in a closed chamber on the stage of an inverted microscope. The chamber was perfused with HEPES-buffered solution (mM: 140 NaCl, 1 KCl, 1 MgSO 4, 2 CaCl2, 2.5 NaH2PO4, 5.5 glucose, 10 HEPES, pH 7.5) and then with HCO 3 Ϫ /CO2-buffered solution (33 mM NaHCO3, 5% CO2 replaced 33 mM NaCl; pH 7.5). The dye was excited with 490 and 440 nm light using a Lambda 10-2 filter wheel controller (Sutter Instruments, Novato, CA), and the 535 nm emission lights from both excitations (i.e., I 490 and I440) were captured using Nikon NIS Elements AR 3.0 (Nikon, Melville, NY). The ratio of I490/I440 was calculated after background subtraction. Dye calibration was made by the nigericin method (37) . The rate of pHi change was calculated from the slope of a linear regression line during the first 90 s of recovery from CO 2-induced acidification.
Cellular localization of NBCn1⌬450 in HEK 293 cells. NBCn1-E (i.e., SLC4A7-005) and NBCn1⌬450 were fused to the COOHterminal end of yellow fluorescence protein (YFP) in pEYFP-C1 (Clontech, Mountain View, CA). HEK 293 cells were transfected with pEYFP/NBCn1-E or pEYFP/NBCn1⌬N450, and the endoplasmic reticulum (ER) marker DsRed-ER (Clontech). The control was pEYFP-C1. Cells were visualized with excitation/emission filter sets of 490/530 nm for YFP-tagged proteins and 560/585 nm for DsRedtagged proteins using Nikon E600W Eclipse confocal microscope. Images were captured using Nikon EZ-C1 software. Quantitative The clusters were identified by analyzing human genomic and cDNA sequences in the DBTSS database. Intron 7 contains 2 clusters separated by Ͼ 500 bp. The numbers of the 2 clusters were combined. measurement of fluorescence was done using the protocol (17) with slight modification. Fluorescence images (ϫ40) were converted to 8-bit grayscale images and analyzed with the same threshold of 50 (0 for white and 255 for black) to validate comparisons between signals from YFP-tagged transporters. The pixel intensities of the labeling in membranes and cytosol were selected for analysis. The plasma membrane expression of NBCn1-E in HEK 293 cells has been demonstrated previously (16, 30) and therefore NBCn1-E fluorescence serves as a plasma membrane marker. The cytosol is defined by the compartment separated by plasma membranes. The pixel intensity of fluorescence in plasma membrane was measured by randomly positioning small boxes (10 at a time) at different locations along the membrane. The intensity of fluorescence in cytosol was also measured by randomly positioning the equal numbers of boxes in the area separated by plasma membranes. The area of the nucleus and the area close to the plasma membrane were not used. Background was determined by positioning boxes in the area where there was no labeling. Analysis was done with ImageJ with the JACoP plug-in.
Expression of E326K in Xenopus oocytes. The mutant transporter E326K was constructed using NBCn1-A that contains amino acids encoded from exon 8 (position 251-374) by site-directed mutagenesis. E326K expression and function were performed in Xenopus laevis oocytes using the protocol (13) . Briefly, oocytes at stages V and VI were injected with 46 nl of NBCn1-A or E326K cRNAs (0.4 g/l) or water and maintained for 3-4 days at 18°C. Thin-wall borosilicates were filled with the proton ionophore 1 cocktail B (Sigma-Aldrich, St. Louis, MO) back-filled with the phosphate buffer for pH electrode and with 3 M KCl for voltage electrode. The pH electrode was connected to the electrometer FD-223 (World Precision Instruments, Sarasota, FL) and then routed to a custom-made subtraction amplifier. The voltage electrode was connected to the voltage-clamp amplifier OC-725C (Warner Instrument, Hamden, CT). Signals from pH and voltage electrodes were sampled by Digidata 1440A, and data acquisition was done using pClamp (Molecular Devices, Sunnyvale, CA). The pH electrode was calibrated using pH 6.0 and 8.0 standards (slope 53 Ϯ 1 V/pH). Oocytes were superfused with ND96 solution (mM; 96 NaCl, 2 KCl, 1.8 CaCl 2, 1 MgCl2, and 10 HEPES, pH 7.4) and then with a solution containing 25 mM HCO 3 Ϫ , 5% CO2 (pH 7.4). Experiments were done at room temperature.
Immunoblot. Oocytes were homogenized in ice-cold buffer (300 mM mannitol, 0.1 mg/ml phenylmethanesulfonyl fluoride, 5 mM HEPES, and 1ϫ protease inhibitor mixture I) and centrifuged at 800 g for 10 min to remove cell debris. The protein concentration in the supernatants was determined using the Bradford reagents (Sigma-Aldrich). Equal amounts of total proteins from the samples were separated on a 7% SDS-polyacrylamide gel and blotted to a nitrocellulose membrane. The blot was incubated with the anti-NBCn1 antibody (34) for 2 h in blocking buffer (5% nonfat dry milk and 0.05% Tween 20 in PBS). The blot was washed with PBS containing 0.05% Tween 20 for 20 min and incubated with the horseradish peroxidase-conjugated goat anti-rabbit IgG (EMD Millipore) for 1 h. After being washed, the blot was treated with ECL chemiluminescence kit (GE Healthcare Bio-Sciences, Piscataway, NJ) to visualize the immunoreactive bands. The blot was reprobed with the mouse anti-␤-actin antibody (EMD Millipore). Densitometric analysis of immunoreactive bands was done using the protocol we previously described (29) . The pixel intensities of the bands were normalized to the intensity of ␤-actin after background subtraction.
Statistical analysis. Data are reported as means Ϯ SE. Levels of significance were assessed by unpaired, two-tailed Student t-test when dpH i/dt and immunoblot signals were analyzed. The P value of Ͻ 0.05 was considered significant. The differences between groups were assessed by one-way or two-way ANOVA with Bonferroni post hoc test. The statistical analysis was performed using GraphPad Prism 7 (GraphPad Software, La Jolla, CA). 
RESULTS
Identification of alternative promoters in intron 7 of human SLC4A7 gene. To locate alternative promoter sites in the SLC4A7 gene, we analyzed human genomic and cDNA sequences in the DBTSS database, which provides information on the 5=-ends of eukaryotic transcripts. A promoter cluster was defined as a genomic region where more than two transcripts have the 5=-ends within 500 bp. Table 1 shows the locations of top four clusters analyzed from 1,231 human adult SLC4A7 cDNAs. In our study, an exon of the SLC4A7 gene is defined as a coding region that produces amino acids in at least one protein isoform. Thus, exon 1 encodes the NH 2 -terminal end of some isoforms while exon 2 encodes that of other isoforms. Exon 8 corresponds to the fingerprint amino acids domain, called cassette II (15) or cassette-␤ (31). These clusters were located in a region upstream of exon 1 and within introns 1, 7, and 23. The cluster located upstream of exon 1 is found in cDNAs from all organs examined and represents the main promoter site for gene transcription. The cluster in intron 1 is found in some organs. These two clusters are the sites that initiate production of transcripts encoding transporters that are complete or alternatively spliced (hereafter, normal transporters), in contrast to the NH 2 -terminally deleted NBCn1⌬450. The interesting result is the presence of a cluster in intron 7, where rs3278 is located. This cluster is found in several organs including the brain, breasts, and kidneys and abundant at the comparable levels to the clusters for normal transcription. The cluster in intron 23 is close to the 3=-end of the coding region and thus unlikely represents a true promoter site. The identified clusters and predicted starts of the coding regions are illustrated in Fig. 1A .
The cluster in intron 7 was further analyzed to determine the promoter sequence. The Neural Network Promoter Prediction algorithm identified three putative promoters located 984 bp (P1), 1,394 bp (P2), and 1,949 bp (P3) from exon 7 (Fig. 1B) .
Their prediction scores are 0.89, 0.99, and 0.99, respectively, which are Ͼ0.8 for nonspecific sequence ( Table 2 ). In addition, the region upstream of intron was examined to identify CpGrich sites that regulate gene expression. Two short CpG sites were identified in intron 6 ( Table 3) .
Promoter activity in intron 7. To examine whether intron 7 has a promoter activity, we isolated the 5,092 bp genomic DNA corresponding to exons 6 -8 and ligated it to a luciferase reporter construct. We then made a series of constructs in which the SLC4A7 DNA insert was sequentially deleted ( Fig.  2A) . Figure 2B shows the results of luciferase activities determined by a ratio of firefly luciferase to an internal control Renilla luciferase in transfected neuroblastoma cells (n ϭ 6 for each). The construct containing SLC4A7 DNA (WT in the figure) produced significant luciferase activity (P Ͻ 0.01; one-way ANOVA with Bonferroni post hoc test). The construct with an inversion of intron 7 (Rev) had negligible activity (0.45 Ϯ 0.06 for pGL-Basic vector control vs. 0.43 Ϯ 0.02 for Rev), indicating that the increased activity in the WT construct is due to the region containing P1-3 promoters, not to an insertion of nonspecific nucleotides. Deletion of the region upstream of the promoters reduced the activity by 85% (P1/2/3; 0.66 Ϯ 0.05; P Ͻ 0.01), whereas deletions that extended to P1 and P2 promoter abolished the activity (0.31 Ϯ 0.04 for P2/3 and 0.37 Ϯ 0.09 for P3), similar to the vector control (P Ͼ 0.05). Thus, the P1 promoter is responsible for promoter activity, which is markedly enhanced by the upstream CpG sites for full activation.
Enhancement of promoter activity by rs3278 and rs3755652. To determine the effect of rs3278 on alternative promoter activity, we substituted the major allele G at rs3278 to the minor allele A and performed luciferase assays. In parallel experiments, major-to-minor allele substitutions were individually made at 3772723 (intron 7), synonymous rs1307740 (exon 8), and nonsynonymous rs3755652 (exon 8). Figure 3 , A: normal and deletion constructs used in the luciferase reporter gene assay. The SLC4A7 DNA corresponding to exon 6 to exon 8 was inserted upstream of a luciferase reporter gene (WT). The Rev construct is an inversion of the region containing 3 promoters (between inverted triangles). The P1/2/3 construct is the deletion that removes CpG sites but maintains all 3 promoters. The P2/3 construct is the deletion that removes P1 but maintains the 2nd and 3rd promoters, and the P3 construct is the deletion that maintains P3 only. B: luciferase activities in neuroblastoma cells transfected with the constructs. Luciferase activity was measured by a ratio of firefly luciferase to the internal control Renilla luciferase (n ϭ 6 for each). The control pGL3-basic (pGL) is the empty reporter plasmid. **P Ͻ 0.05 determined by 1-way ANOVA with Bonferroni post hoc test.
A-D, shows the comparison of luciferase activities in major alleles vs. minor alleles at these SNPs (n ϭ 6 for each). The minor allele at rs3278 increased the luciferase activity by 1.2-fold (P Ͻ 0.01). The minor alleles at rs3772723 and rs13077400 had negligible effects, whereas the minor allele at rs3755652 increased the luciferase activity by 2.2-fold (P Ͻ 0.01). In concomitant substitutions, the minor allele at rs3278 additionally increased rs3755652-mediated activity (P Ͻ 0.01; Fig. 3E ). Thus, the effects of these two SNPs are additive. The substitution at rs3772723 had no effect on rs3755652, consistent with the above single mutation data. rs3755652 affecting P1 promoter. The above finding of increased promoter activity by rs3755652 was unexpected and led us to investigate the marker's target region. For this investigation, we made the major-to-minor allele substitution at rs3755652 in all constructs in Fig. 2A and compared them. Figure 4 shows the results of luciferase activities in these constructs (n ϭ 12 for each group of major and minor alleles; tested at the same time on four occasions; two-way ANOVA with Bonferroni post hoc test). Compared with the major allele, the minor allele markedly increased the promoter activity (second pair of bars in the figure; 1.96 Ϯ 0.10 for the major allele vs. 6.10 Ϯ 0.61 for the minor allele; P Ͻ 0.01). The minor allele in the construct of inverted intron 7 had no effect (third pair of bars), indicating that the P1 promoter in the forward orientation is absolutely necessary for transcription. The minor allele increased the P1 promoter activity by 5.5-fold (fourth pair of bars; 0.66 Ϯ 0.05 for the major allele vs. 3.65 Ϯ 0.62 for the minor allele; P Ͻ 0.01). This increased activity corresponds to~60% of the minor allele's activity in the WT construct. Thus, rs3755652 has more profound effects on the P1 promoter than the upstream CpG sites, despite that the CpG sites are critical for the P1-mediated transcription. The effects of the minor allele on P2 and P3 were not significant (fifth and six pairs of bars; P Ͼ 0.05 for both).
Negligible effects of rs3755652-induced amino acid substitution on transporter function and expression. The major-tominor allele substitution at rs3755652 converts a negatively charged Glu to a positively charged Lys at position 326 in the canonical NBCn1. To examine if this conversion affects Na/ HCO 3 transport function, we made the point mutant E326K using NBCn1-A and measured pH i change mediated by the mutant in Xenopus oocytes. Na/HCO 3 transporters move HCO 3
Ϫ into the cytosol and raise pH i , and thus we recorded pH i recovery from an intracellular acidification in a solution buffered with CO 2 /HCO 3 Ϫ . Figure 5 , A-C, shows representative pH i traces in 5% CO 2 , 25 mM HCO 3 Ϫ in three groups of oocytes injected with water, NBCn1-A, or E326K. The water-injected control had negligible pH i recovery. The oocyte expressing NBCn1-A recovered pH i from an acidification. Similarly, the oocyte expressing the mutant recovered pH i from an acidification. The mean pH i recovery rates were similar Fig. 3 . Effects of major-to-minor allele substitutions at rs3278 and 3 adjacent SNPs on alternative transcription. A-D: comparison of major alleles with minor alleles at rs3278 (intron 7), rs3772723 (intron 7), rs13077400 (exon 8), and rs3755652 (exon 8). Luciferase activities in minor alleles (gray bars) are presented relative to those in major alleles (open bars). Fold change was calculated by dividing the major and minor allele data points by the mean of the major allele points in each experiment. The major allele error bars represent variations among controls. n ϭ 6 for rs3278, rs3772723, rs13077400, and 9 for rs3755652. E: effect of rs3278 on rs3755652-mediated luciferase activity. Concomitant substitutions at rs3278 or rs3772723 were made on the construct containing rs3755652 minor allele. Luciferase activities are presented relative to the activity produced by rs3755652 minor allele substitution (n ϭ 6 -12 for each). Fig. 4 . Identification of the genomic region affected by rs3755652. The minor allele at rs3755652 was made in all of the constructs shown in Fig.  2A . Both alleles were tested at the same time on 4 occasions (n ϭ 12 for each group of alleles). Statistical significance was determined by 2-way ANOVA with Bonferroni post hoc test.
(12.6 Ϯ 4.9 ϫ 10 Ϫ5 dpH i /s for NBCn1-A vs. 13.1 Ϯ 1.8 ϫ 10 Ϫ5 dpH i /s for E326K; P Ͼ 0.05; n ϭ 4 for each; Fig. 5D ). The resting pH i before CO 2 /HCO 3 Ϫ application was similar among oocytes, validating the comparison. Immunoblotting of oocyte membranes with the NBCn1 antibody showed similar expressions of the two proteins (Fig. 5, E and F) . Taken together, these data indicate that rs3755652 increases P1mediated alternative transcription without affecting NBCn1 function and expression.
Defects in NBCn1⌬450 function and expression. Among different isoforms, NBCn1⌬450 starts with a frameshift in exon 9 and thus is predicted to be under the regulation of the P1 promoter. To examine whether NBCn1⌬450 is functional, we expressed it in HEK 293 cells and recorded pH i recovery from an acidification. Figure 6A shows mean pH i traces in transfected cells in the presence of 5% CO 2 , 33 mM HCO 3 Ϫ (n ϭ 8 for each). Solutions contained 100 M EIPA to block endogenous Na/H exchangers. In cells expressing nontruncated NBCn1-E, the pH i recovered from an acidification. However, in cells expressing NBCn1⌬450, the recovery was negligible. Figure 6B summarizes mean recovery rate calculated during the first 90 s from an acidification. The mean dpH i /dt for NBCn1⌬450 was 0.68 Ϯ 0.21 ϫ 10 Ϫ4 pH units/s, significantly lower than 2.82 Ϯ 0.27 ϫ 10 Ϫ4 pH units/s for NBCn1-E (P Ͻ 0.05). The NBCn1⌬450 recovery rate was similar to the control (0.77 Ϯ 0.22 ϫ 10 Ϫ4 pH/s; P Ͼ 0.05). The resting pH i and the CO 2 -induced acidification were similar in all three groups of cells, indicating that the buffering powers were not different.
To examine whether NBCn1⌬450 membrane expression is altered, we constructed YFP/NBCn1⌬N450 and YFP/ NBCn1-E and expressed them in HEK 293 cells. Determined by YFP fluorescence, NBCn1⌬450 was lower in plasma membrane but instead more abundant in the cytoplasm (Fig. 7, A  and B) . Quantitative measurement of fluorescence confirmed different expression levels between the two proteins ( Fig. 7C ). In the cytoplasm, NBCn1⌬450 fluorescence was in puncta and only weakly colocalized with the ER marker DsRed-ER fluorescence ( Fig. 7, D-I) . Thus, NBCn1⌬450 does not get stuck in the ER.
DISCUSSION
The major findings from this study are as follows: 1) Computational sequence analysis and luciferase reporter assays reveal an alternative promoter activity in intron 7 of the human SLC4A7 gene. 2) The alternative transcription from intron 7 is enhanced by rs3278 located upstream of the P1 promoter.
3) The alternative transcription is also enhanced by nonsynony- .pHi recovery after an initial CO2-induced acidification represents a typical transport activity of NBCn1-A. The pHi recovery by E326K is similar to that for NBCn1-A. D: summary data from the experiments similar to those in A-C on the rate of pHi recovery (pHi per second ϫ 10 Ϫ5 ; n ϭ 4 for each). E: immunoblotting of transporters. Crude membranes of oocytes expressing NBCn1-A or E326K were isolated and subjected to immunoblotting with the anti-NBCn1 antibody. The blots were striped and reprobed with the anti-␤-actin antibody. One of 3 experiments is shown. F: quantitative measurements of immunoreactive protein bands. The pixel intensity of NBCn1-A or E326K was measured and normalized to ␤-actin (n ϭ 3). mous rs3755652 in exon 8. 4) The missense mutation E326K caused by rs3755652 does not affect transporter function. 5) NBCn1⌬450 has a defect in membrane expression and function. Conclusively, out study provides evidence, for the first time, of the genomic role of rs3278 in SLC4A7 gene transcription. Our study also recognizes rs3755652 as a SNP affecting an alternative transcription.
Using bioinformatic tools, we identified a promoter cluster containing P1, P2, P3 sequences in intron 7. All of these sequences lack a typical TATA box that is found 25-35 bp upstream of a transcription start site, but many eukaryotic genes, particularly housekeeping genes, do not have this box (24) . The multiple promoters or promoter-like sequences are the result of natural selection for function (23) . A cluster of promoter-like sequences is known to play a regulatory role through structural or functional interaction with an active promoter site. In our study, the P1 promoter is an active promoter responsible for alternative transcription while P2 and P3 are promoter-like sequences. P1 has a lower prediction score than both P2 and P3 but is closer to the upstream CpG-rich sites. The CpG sites are commonly located near the flanking regions of a promoter site to regulate gene expression by methylation although they can also be found far distant from a promoter (26) . The CpG sites identified in our study are shorter than a typical CpG island that has more than 200 bp in size. Nevertheless, the presence of multiple small CpG sites appears to have more impacts on gene regulation as the region containing the two CpG sites contributes to 85% of the total alternative transcription in intron 7 (Fig. 2) .
The most significant finding in our study is that the P1mediated alternative transcription is enhanced by adjacent SNPs. The distance between rs3278 and P1 is not too far (928 bp), consistent with the report (32) that disease-associated SNPs are significantly enriched within promoter-interacting regions in human genomes, compared with SNPs of no phenotype. Similarly, rs3755652 is located 1,437 bp downstream from P1. This SNP affects not only the active P1 promoter, but also the region containing two CpG sites, although the latter effect is less profound. Our study has no information on how rs3278 and rs3755652 affect the promoter, but it has been well documented that SNPs in the promoter region of a gene typically alter a promoter binding affinity to transcription factors. The effects of the two SNPs are additive, indicating their simultaneous presence will likely produce more profound effects than single SNPs. According to the HapMap Project of the National Institutes of Health, rs3278 and rs3755652 are in the linkage disequilibrium block with other SNPs located between introns 4 and 9. It is interesting to note that the minor allele frequency of rs3278 in the COGA sample is 0.123 for alcoholics and 0.059 for controls, while the frequency of rs3755652 is 0.336 for alcoholics and 0.237 for controls (25) . The minor allele at rs3755652 leads to a missense mutation in the normal transporter but does not affect its function and expression, consistent with the recent report of negligible effect of the mutant expressed in rat arotic smooth muscle cells (33) . This lack of effect was predictable considering variable amino acid substitutions in the corresponding position among species. Glu 326 is replaced with Gln, His, or Arg depending upon the animal. The minor allele at rs3755652 is advantageous for alternative transcription as it upregulates NBCn1⌬450 without affecting the expression and function of normal NBCn1.
What would be the role of the NH 2 -terminal 450 amino acids? Boron et al. (7) have discussed that the Na/HCO 3 transporters can be functionally compartmentalized into variable regions (VRs), which play a regulatory role, and conserved regions (CRs), in which subtle changes may be associated with functional differences among the members of Na/ HCO 3 transporters. Based on this compartmentalization, three VRs and two CRs are juxtaposed to one another in the cytoplasmic NH 2 -terminal domain of NBCn1. Among them, VR1, VR2, and CR1 are missed in NBCn1⌬450. The function of VR1 is unclear, but, in NBCe1, this region serves as a docking domain to IP 3 receptor-binding protein released with inositol 1,4,5-trisphosphate (39, 40) . VR1 has an autoregulatory effect on the unitary transporter activity. In NBCn1, VR2 affects protein expression in membranes (45) , tissue-specific distribution (15) , and calcineurin binding (18) . CR1 is highly conserved and may serve as a structural pat of the protein.
Taking this information together, we think that impaired expression and activity of NBCn1⌬450 is due to the lack of VR2 and CR1. In NBCe1, CR1 contains a glutamine at position 91, which interacts with an arginine at 298 in CR2 and forms part of the tunnel involved in an ion-translocation pathway (10) . Thus, the lack of CR1 may disrupt transport function. In the cytoplasm, NBCn1⌬450 does not get stuck in the ER, but its membrane expression is low, thus indicating an instability of the protein in membranes. It is possible that the protein turnover rate is altered so that NBCn1⌬450 is internalized more frequently. We think that this abnormal turnover rate of NBCn1⌬450 would influence the expression of normal NBCn1 in membranes. Given the fact that bicarbonate transporters including NBCn1 form dimers (9, 27, 44) , an abnormal turnover of NBCn1⌬450 may facilitate NBCn1 internalization.
The finding of increased alternative transcription by SNPs leads us to discuss the potential role of NBCn1 in addiction, especially alcoholism. Alcohol is metabolized to acetaldehyde in the cytosol and then to acetate in mitochondria primarily in the liver. This metabolism increases the ratio of NADH to NAD ϩ , which stimulates lactate and ketone body production causing systemic metabolic acidosis (22, 46) . NBCn1 is upregulated during metabolic acidosis in animals and by acidification in vitro (5, 34, 38) to inhibit pH i from falling far below normal. pH influences activities of addiction-related proteins such as NMDA receptors and GABA receptors (4). For example, the NMDA receptors have the half-maximum inhibition of pH at physiological ranges (11) and are involved in alcoholism features including ethanol tolerance, dependence, withdrawal, and relapse (35) . This suggests that a disruption of synaptic pH homeostasis by abnormal NBCn1 would alter receptor activity, thereby changing alcoholism-related synaptic activity. Furthermore, NBCn1 clusters with NMDA receptor proteins via protein-protein interaction (28) . Thus, an abnormal upregulation of NBCn1 during alcohol-induced metabolic acidosis will likely change interactions with other proteins in addition to pH homeostasis. Such changes may result in alteration of synaptic activity in certain alcoholism-related neurons. Consistent with this idea, our preliminary study shows that slc4a7 knockout mice drink more alcohol and also have increased sensitivity to alcohol-induced sedation (Jesse Schank, unpublished observation). Thus, abnormalities in NBCn1 affect alcohol-drinking behaviors of mice.
In summary, our study shows that rs3278 and rs3755652 enhance an alternative transcription of the SLC4A7 gene. This gives a different perspective and approach to understanding SNPs, because alternative transcription induced by gene polymorphisms is not readily identified by gene array or proteomic approaches but can be recognized by hypothesis-driven approaches. In addition, our study puts SLC4A7 as a candidate gene for addiction and leads to the development of a new concept that acid-extruding NBCn1 affects the propensity of alcoholism in particular and addiction in general.
